Profound Medical Corp.
PROF
$6.32
-$0.11-1.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.98M | -15.70M | -10.72M | -5.33M | -9.37M |
| Total Depreciation and Amortization | 147.00K | 141.00K | 163.00K | 212.00K | 214.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -136.00K | -- |
| Total Other Non-Cash Items | 1.67M | 1.44M | 1.03M | 382.00K | 664.00K |
| Change in Net Operating Assets | -3.45M | 366.00K | 1.25M | -766.00K | 1.66M |
| Cash from Operations | -9.61M | -13.74M | -8.28M | -5.64M | -6.83M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -290.00K | -523.00K | -592.00K |
| Issuance of Common Stock | -- | -- | -- | 39.21M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -3.04M | 0.00 |
| Cash from Financing | 0.00 | 0.00 | -290.00K | 35.65M | -592.00K |
| Foreign Exchange rate Adjustments | -755.00K | 2.51M | 94.00K | -2.22M | 462.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.37M | -11.24M | -8.48M | 27.79M | -6.96M |